Maria Kyrgiou
Papers
2
Total Citations
63
H-Index
2
About
Maria Kyrgiou is a leading figure in gynaecological oncology, whose research has fundamentally advanced the screening and surgical management of cervical and endometrial cancers. Her work is at the forefront of integrating cutting-edge metabolomics into clinical practice, most notably through her pioneering development of laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS). Her landmark 2020 paper on this technology—cited 45 times—demonstrates its potential as a powerful, real-time metabolomics platform for cervical cancer screening, offering a novel triage method for women testing positive for high-risk HPV, a critical improvement over the limitations of reflex cytology. Beyond screening, Kyrgiou has made substantial contributions to surgical oncology. Her influential 2022 study, with 18 citations, rigorously compared minimally invasive surgery to open surgery for high-risk endometrial cancer, providing crucial evidence that shapes surgical decision-making for this complex patient population. Her work directly addresses the challenges of rising HPV-positive screening rates and the need for more precise, less invasive treatments, cementing her reputation as a transformative researcher whose insights are directly improving patient outcomes and guiding clinical guidelines worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2